9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy

Global study sets new risk-based standard to personalise chemotherapy for colon cancer after surgery

Olaparib slows growth of BRCA-related metastatic breast cancer

Web-based system for self-reporting symptoms may help patients live longer

3 or 6 months adjuvant oxaliplatin for colorectal cancer

No link between pregnancy and breast cancer relapse

Pooled analysis of avelumab for metastatic urothelial carcinoma

Cancer and living meaningfully: the CALM intervention

Larotrectinib shows durable efficacy across diverse paediatric and adult cancers

Routine genomic testing is feasible, but only a subset of patients benefit

Molecular profiles and the future of adjuvant therapy

Pregnancy after breast cancer no associated with relapse risk